Delivery Order SPE2DB22D3501-SPE2DB24FUN36
Award Date 2/9/24
Potential Completion Date 2/12/24
Potential Value $3.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,166.39 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 5-160 MG TABLET 30S pharmaceuticals. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,001.00 firm fixed-price delivery order is for the supply of EXFORGE 10-160 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order, valued at $3,721.70, is for the supply of 4565296476 - EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance through July 31, 2024 and uses a Firm Fixed Price pricing type. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The award is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $3,365.33 and a performance period ending on April 7, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,089.05 contract is for the provision of 4563783806 EXFORGE 5-320 MG TABLET 30S, a pharmaceutical product, with a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,628.78 Firm Fixed Price Delivery Order covers the supply of EXFORGE 5-160 MG TABLET 30S, a cardiovascular medication, with a period of performance through January 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,496.69 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 10-320 MG TABLET 30S pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,321.60, is for the delivery of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,090.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $7,839.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the provision of EXFORGE 5-320 MG TABLET 30S, a pharmaceutical product, to support military healthcare...